Semaglutide therapy involves the use of a peptide
medication called Semaglutide to manage conditions such as obesity and type 2 diabetes. Semaglutide is a GLP-1 receptor agonist that works by increasing feelings of fullness, reducing appetite, and improving blood sugar control.

Semaglutide therapy may be
recommended for individuals who are overweight or obese and have struggled to achieve weight loss through diet and exercise alone. It is also indicated for individuals with type 2 diabetes who require additional glycemic control.

Semaglutide is typically administered as a once-weekly injection under the skin (subcutaneous injection). The dosage may be adjusted based on individual response and tolerability. Your healthcare provider will provide detailed instructions on how to administer Semaglutide safely and effectively.

Common side effects of Semaglutide therapy may include nausea, vomiting, diarrhea, constipation, and decreased appetite. These side effects are usually mild to moderate in severity and tend to improve over time. Serious side effects such as pancreatitis and allergic reactions are rare but may occur. It's important to discuss any concerns with your healthcare provider.

The timeline for experiencing weight loss and improvements in blood sugar control with Semaglutide therapy can vary from person to person. Some individuals may start to see results within a few weeks of starting treatment, while others may require several months to achieve significant changes. Consistency with treatment and adherence to lifestyle modifications
are essential for optimal outcomes.